Your browser doesn't support javascript.
loading
Cost-utility analysis of cataract surgery in the United States for the year 2018.
Brown, Gary C; Brown, Melissa M; Busbee, Brandon G.
Afiliación
  • Brown GC; Center for Value-Based Medicine, Hilton Head, South Carolina; Eye Research Foundation, Philadelphia, Pennsylvania; Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania; Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia. Electronic address: gbrown@valuebasedmedicine.com.
  • Brown MM; Center for Value-Based Medicine, Hilton Head, South Carolina; Eye Research Foundation, Philadelphia, Pennsylvania; Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania; Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
  • Busbee BG; Tennessee Retina, Nashville, USA.
J Cataract Refract Surg ; 45(7): 927-938, 2019 07.
Article en En | MEDLINE | ID: mdl-31262482
PURPOSE: To perform a cost-utility analysis of 2018 United States real dollars for cataract surgery. SETTING: Center for Value-Based Medicine, Hilton Head, South Carolina, USA. DESIGN: Cost-utility analysis. METHODS: A base-case 14-year cost-utility model using the ophthalmic cost perspective was used. Third-party insurer and societal cost perspectives were also analyzed. Patient outcomes and costs were discounted with net present value analysis at 3% a year. RESULTS: First-eye cataract surgery resulted in a 2.523 quality-adjusted life-year (QALY) gain, a 33.3% patient value gain, and 25.5% quality-of-life gain. Bilateral surgery yielded a 44.1% patient value gain, while second-eye cataract surgery alone conferred an 8.1% value gain. First-eye cataract surgery resulted in a gain of 2.52 QALYs, while second-eye surgery added an incremental gain of 0.81 QALYs. The ophthalmic-cost-perspective average cost-utility ratio was $2526/2.523 = $1001/QALY for first-eye cataract surgery. The societal-cost-perspective average cost-utility ratio was -$370 018/2.523 = -$146 629/QALY. The second-eye ophthalmic-cost-perspective cost-utility ratio was $2526/0.814 = $3101/QALY, while the ophthalmic-cost-perspective cost-utility ratio for bilateral cataract surgery was $5052/3.338 = $1514/QALY. The 14-year U.S. 2018 real-dollar societal-cost-perspective net return on investment for first-eye cataract surgery was $370 018 above the $2526 cost expended for cataract surgery. CONCLUSIONS: Cataract surgery in both the first eye and second eye, when analyzed by standard health economic methodologies, is highly cost-effective. Cataract surgery in 2018 was 73.7% more cost-effective than in 2000.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Extracción de Catarata / Costos de la Atención en Salud Tipo de estudio: Health_economic_evaluation / Observational_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: J Cataract Refract Surg Asunto de la revista: OFTALMOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Extracción de Catarata / Costos de la Atención en Salud Tipo de estudio: Health_economic_evaluation / Observational_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: J Cataract Refract Surg Asunto de la revista: OFTALMOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos